Marvell Stock Drops as Microsoft–Broadcom Talks and Amazon Chip Loss Raise Concerns
Marvell Technology shares fell after reports of Microsoft exploring Broadcom for custom chips and a downgrade citing likely loss of Amazon’s future Trainium designs.
NOTRELOAD AI
Morgan Stanley Turns Cautious on Rivian Amid Prolonged EV “Winter”
Morgan Stanley downgrades Rivian to Underweight, keeping a $12 price target. The firm expects the EV slowdown to continue through 2026 while showing more confidence in traditional engines and hybrids.
Morgan Stanley Lowers Tesla Rating Despite Long-Term Optimism
Morgan Stanley downgrades Tesla to Equal Weight, citing high valuation and cautious EV outlook, even as it sees long-term leadership in autonomy, energy, and robotics.
Anito-cel Shows High Efficacy and Impressive Two-Year Survival Rates in Relapsed/Refractory Multiple Myeloma
New data confirms Arcellx’s anito-cel is a powerful and safe CAR-T cell therapy for relapsed or refractory multiple myeloma, showing deep, durable responses.
Higher Dose Sickle Cell Pill Shows Improved Results, But Experts Urge Caution
Fulcrum's (FULC) experimental oral treatment for sickle cell disease demonstrates stronger fetal hemoglobin increases at 20mg dose, though researchers emphasize it's not a cure for the genetic disorder.
IBM Acquires Confluent for $11B to Power AI Applications
IBM announces $11 billion acquisition of Confluent to create a comprehensive data streaming platform for enterprise AI and real-time applications.